Mozambique

Overview

In Mozambique, there are approximately 1.8 million people living with HIV, including 200,000 children, 14 years of age and younger.
Download Country Fact Sheet

Key Program Accomplishments

Since 2004, EGPAF-Mozambique has:

Prevented the transmission of HIV to almost 40,000 babies

Started more than 210,000 women living with HIV on antiretroviral therapy (ART)

Provided health services to more than 2,385,000 individuals

Provided prevention of mother-to-child HIV transmission (PMTCT) services to nearly 2,400,000 pregnant women

Our Work

In 2004, the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) began implementing a prevention of mother-to-child HIV transmission (PMTCT) program in the Nampula, Cabo Delgado, Maputo, and Gaza provinces in Mozambique. Currently, EGPAF-Mozambique supports the Ministry of Health in providing HIV services at 194 health facilities in Gaza, and supports performance-based financing (PBF) efforts in Nampula and Gaza.

EGPAF works in close partnership with the Ministry of Health to ensure that women, children, and families living with and affected by HIV and AIDS receive the care and treatment they need to lead healthy and active lives. EGPAF-Mozambique’s work includes increasing and expanding access to HIV-related services, strengthening existing PMTCT and HIV care and treatment services, and improving monitoring and evaluation systems. We also aim to improve the capacity of national, local and provincial health departments, health facilities, and communities and contribute to the development and implementation of national health policies and guidelines. We collaborate with community-based organizations to sensitize and mobilize local communities around HIV/AIDS issues.

We are dedicated to the advancement of operations research focused on the improvement of prevention, care and treatment of HIV and AIDS in Mozambique. Current research projects include an assessment of institutional barriers to access post-exposure prophylaxis and related services by sexual violence survivors, a program evaluation of the index case HIV testing approach, and an analysis of trends in male-female ratio among adult (15 years or age and older) patients receiving EGPAF-supported HIV and TB services. Past research projects have examined seroconversion in pregnant and lactating women, decentralized screening of TB, the impact of performance-based financing and barriers to pediatric HIV care.

EGPAF promotes sustainability of HIV/AIDS programs in-country. In so doing, we developed and increased the capacity of our local affiliate organization, Fundação Ariel Glaser contra o SIDA Pediátrico. With funding from U.S. Centers for Disease Control and Prevention, Fundação Ariel Glaser has expanded HIV prevention, care and treatment services to 194 sites in Maputo and Cabo Delgado provinces. Fundação Ariel provides sub-grants and technical assistance to health authorities and community-based organizations, which strengthens national capacity to effectively scale-up and sustain HIV, TB, and maternal and child health services.

Projects


Resources